Patent details

EP3280448 Title: ABIRATERONE ACETATE LIPID FORMULATIONS

Basic Information

Publication number:
EP3280448
PCT Application Number:
EP2016056689
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167118314
PCT Publication Number:
WO2016162229
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ABIRATERONE ACETATE LIPID FORMULATIONS
French Title of Invention:
FORMULATIONS LIPIDIQUES D'ACÉTATE D'ABIRATÉRONE
German Title of Invention:
ABIRATERON-ACETAT-LIPIDFORMULIERUNGEN
SPC Number:

Dates

Filing date:
25/03/2016
Grant date:
30/12/2020
EP Publication Date:
14/02/2018
PCT Publication Date:
13/10/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/12/2020
EP B1 Publication Date:
30/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/03/2021
Expiration date:
25/03/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/12/2020
 
 

Name:
Capsugel Belgium NV
Address:
Rijksweg 11, 2880 Bornem, Belgium (BE)

Inventor

1

Name:
JULE, Eduardo
Address:
Belgium (BE)

2

Name:
AGARWAL, Prashant
Address:
United States (US)

3

Name:
WILLIAMS, Hywel
Address:
Australia (AU)

Priority

Priority Number:
201562145864 P
Priority Date:
10/04/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/10; A61K 9/14; A61K 9/48; A61K 31/58; A61K 47/06; A61K 47/14;

Publication

European Patent Bulletin

1

Issue number:
202053
Publication date:
30/12/2020
Description:
Grant (B1)

2

Issue number:
202105
Publication date:
03/02/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages